Íàó÷íàÿ ëèòåðàòóðà
booksshare.net -> Äîáàâèòü ìàòåðèàë -> Ìåäèöèíà -> Ëàíãå Ð.Ï. -> "Àòëàñ çàáîëåâàíèé ïîëîñòè ðòà" -> 190

Àòëàñ çàáîëåâàíèé ïîëîñòè ðòà - Ëàíãå Ð.Ï.

Ëàíãå Ð.Ï., Ìèëëåð Ê.Ñ. Àòëàñ çàáîëåâàíèé ïîëîñòè ðòà — Ì.: ÃÝÎÒÀÐ, 2008. — 224 c.
ISBN 978-5-9704-0578-9
Ñêà÷àòü (ïðÿìàÿ ññûëêà): pharmazeutischewirkstoffe1982.djvu
Ïðåäûäóùàÿ << 1 .. 184 185 186 187 188 189 < 190 > 191 192 193 194 195 196 .. 345 >> Ñëåäóþùàÿ

DOS 1 817 794 (Sumitomo; Anm. 20.12.1968; J-Prior. 25.12.1967).
K. Ihizumi et al., J. Org. Chem. 37,4111 (1972).
Indol-Vorprodukt:
USP 3 770767 (Sumitomo; ert. 6.11.1973; J-Prior. 28.12.1967).
J: Erimin® (Sumitomo)
Nimorazol 6506-37-2 Chemotherapeuticum
(Nitrimidazine) (Trichomonacid)
4-[2-(5-mtroimidazoI-l-yl)ethyl]morpholine
4- bzw. 5- 2-Morpholinoethylchlorid
Nitroimidazol
(Natrium-Salz)
Nimorazol
Nimorazol - Nimustin - Niridazol N 639
DOT 6,185 (1970); 7,193 (1971).
USP 3 399 193 (Carlo Erba; ert. 27.8.1968; Prior. 4.8.1965).
USP 3458 528 (Merck & Co.; ert. 29.7.1969; Prior. 7.7.1965,18.5.1966). USP 3 646 027 (Merck & Co.; ert. 29.2.1972; Prior. 7,7.1965,18.5.1966).
3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-l-(2-chloroethyl)-l-nitrosourea
DOF3, 52 (1978); 5, 51 (1980).
DOS 2257 360 (Sankyo; Anm. 20.11.1972; J-Prior. 20.11.1971, 4.12.1971, 26.7.1972). USP 4003 901 (Sankyo; ert. 18.1.1977; J-Prior. 20.11.1971,4.12.1971,26.7.1972).
J: Nidran® (Sankyo)
C. R. Lambert et al., Experientia 20,452 (1964).
GB-P 986 562 (Ciba; Anm. 22.5.1963; CH-Prior. 30.5.1962, 23.4.1963). Alternativ-Verfahren:
DAS 2 033 611 (Egyt; Anm. 7.7-1970; H-Prior. 7.7.1969).
DAS 2 117 050 (Egyt; Anm. 7.4.1971; H-Prior. 16.4.1970).
F: Ambilhar® (Ciba)
D: Acterol® forte (Lappe)
Esclama® (Montedison Farma) F: Naxogyn® (Carlo Erba)
Venugyl® (Carlo Erba)-Komb.
GB: Naxogin® (Carlo Erba)
Nulogyl® (Bristol) I: Naxogin® (Erba) Sirledi® (Cansyth)
Nimustin
(ACNU)
42471-28-3
Cytostaticum
4-Amin©-5-arrMn©ffiethyl- 2-Chlorethylisocyanat 2-methylpyrimidin
Nimustin
Niridazol
61-57-4
Chemotherapeuticum (gegen Bilharziose und Amoebiasis)
l-(5-nitro-2-thiazolyl)-2-imidazolidinone
2-Amino-5-nitro- 2-ChlorethyUsocyanat thiazol
640 N Nitrazepam
Nitrazepam
146-22-5
Hypnoticum
l,3-dihydro-7-nitro-5-phenyl-2H-l,4-benzodiazepin-2-one
0
[Pyridin]
Y + H6C2° cH2 * на ——-* nh2
2-Amino- Glycinethylester-
benzophenon Hydrochlorid
HNQ3/HzS0t
2-Oxo-5-phenyt-
2,3-dihydro-IH-
1/-benzodiazepin
02N
H о !
.N^ '
N
Nitrazepam
Alternativsynthese:
6
2-Chlor-5-nitro- p-Toluolsulfonamid
benzophenon
Na-NH-SQ2—CH3
(Na-Salz)
CH3
,xkc;
6
NH2 45ci0ocs
Glyanethylesttr-
HydrocMorid
Nitrazepam
* 2-Amino-5-nitro-benzophenon
DOT 1, 132 (1965); 9,237 (1973).
USP 3 109 843 (Hoffmann-LaRoche; ert. 5.11.1963; Anm. 21.6.1962; Prior. 28.7.1961,4.12.1961). USP 3 116203 (Hoffmann-LaRoche; ert. 31.12.1963; Prior. 14.3.1962).
USP 3 123 529 (Hoffmann-LaRoche; ert. 3.3.1964; Prior. 9.3.1962).
DBP 1136709 (Hoffmann-LaRoche; Anm. 7.12.1960; USA-Prior. 10.12.1959,27.6.1960).
DBP 1 145 626 (Hoffmann-LaRoche; Anm. 7.12.1960; USA-Prior. 10.12.1959,15.1.1960,26.4.1960,
27.6.1960).
L. H. Sternbach et al., J. Med. Chem. 6,261 (1963).
* DAS 1 811785 (Delmar Chemicals; Anm. 29.11.1968; CDN-Prior. 29.11.1967).
Kondensation von 2-Aminobezophenon mit Glycin und POCl3/Nitrobenzol und nachfolgende Nitriening mit KN03/H2S04;
DOS 2252 378 (Roche; Anm. 25.10.1972; CH-Prior. 18.11.1971).
D: Mogadan® Roche (Roche) F: Mogadon® (Roche)
GB: Mogadon® (Roche) Nitrados® (Berk) Somnite® (Norgine)
I: Mitidin® (Savoma) Mogadon® (Roche) Noctem® (Alfa Farm.)
Persopir® (Ion) Prosonno® (Von Boch) Quill® (Ellea) Sonnolin® (Dima)
Tri® (Vita)
J: Benzalin® (Shionogi) Nelbon® (Sankyo) USA: Mogadon® (Roche)
Nitrofurai - Nitrofurantoin N 641
Nitrofurai 59-87-0 Oberflachenantisepticum
(Nitrofurazon)
5-nitro-2-furaldehyde semicarbazone
02N~^°V-CH0 o2nWch=n-nh-co-nh2
* H2N-NH-CO-NH2 • HCl -» \J
5 -Nitro furfural Semicarbazid-Hydrochlorid Nitrofurai
USP 2 416 234 (Eaton Labs.; ert. 1947; Prior. 1945). USP 2 927 110 (Norwich Pharmacal; ert. 1.3.1960; Anm. 23.1.1958).
D: Furacin®-Sol u. -Streusol (Rohm Pharma) J: Monafuracin® (Dainippon)
GB: Furacin® (Eaton) USA: Furacin® (Eaton)
I: Furacin® (Formenti)
Nitrofurantoin 67-20-9 Chemotherapeuticum
{insbesondere gegen Harnwegsinfektionen)
l-(5-nitrofurfurylideneamino)hydantoin
C0-NH2
h2n-nh2
Hydraztn
(Hydrat)
Cl-CHi-COOH
Chloressigsaure
H2N-NH-CH2-COOH
2-Hydrazinoessigsaure
Kalium-
cyanat
H2N-
0
Й
‘N NH
(^N^^-CHtO-CO-CHih
5-Nitrofurtural-diacetvlacetat (2-Oiacetoxyrnethyt-S -nitrc-furan)
h2n-n4
CH2“C00H
Semicarbazido-
essigsaure
USP2610 181 (Eaton Labs.;ert. 1950; Prior. 1950). USP 2 779 786 (Norwich; ert. 29.1.1957; Prior. 17.4.1953). USP 2 898 335 (Norwich; ert. 4.8.1959; Prior. 28.2.1958). USP 2 927 110 (Norwich; ert. 1.3.1960; Prior. 23.1.1958). Besondere galenische Formulierungen: USP 3 401221 (Norwich Pharmacal; ert. 10.9.1968; Prior. 25.8.1964). USP 4122 157 (Richardson-Merrell; ert. 24.10.1978; Anm. 4.3.1977). Retard-Form: DOS 2 749 745 (Chem. Fabrik von Heyden; Anm. 7.11.1977; F-Prior. 15.9.1977).
D: Cystit® (Heyden)
Fua-Med® (MED Fabrik)
Furadantin®/retard (Boehringer Mannh.) Ituran® (Promonta)
Nitrofurantoin retard-ratiopharm (ratiophaim) Phenurin® (Merckle)
Urolong® (Dragees (Thiemann) Uro-Tab\inen® (Sanorania)
Ïðåäûäóùàÿ << 1 .. 184 185 186 187 188 189 < 190 > 191 192 193 194 195 196 .. 345 >> Ñëåäóþùàÿ

Ðåêëàìà

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed

Åñòü, ÷åì ïîäåëèòüñÿ? Îòïðàâüòå
ìàòåðèàë
íàì
Àâòîðñêèå ïðàâà © 2009 BooksShare.
Âñå ïðàâà çàùèùåíû.
Rambler's Top100

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed